Regulation of potassium channels by nonsedating antihistamines.
about
Inhibition of HERG1 K(+) channels by the novel second-generation antihistamine mizolastineArrhythmogenic mechanisms of non-sedating antihistamines.Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity.Inhibition of the rapid component of the delayed-rectifier K+ current by therapeutic concentrations of the antispasmodic agent terodiline.Inhibition of HERG potassium channels by the antimalarial agent halofantrineClinical relevance and management of drug-related QT interval prolongation.Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models.Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels.Highlights in cardiovascular effects of histamine and H1-receptor antagonists.Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine.Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes.Mechanism of block of hEag1 K+ channels by imipramine and astemizole.Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.Effects of cetirizine on the delayed K+ currents in cardiac cells: comparison with terfenadine.Simultaneous gene expression signature of heart and peripheral blood mononuclear cells in astemizole-treated rats.Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure.
P2860
Q28344933-8FCE8A70-2FEF-44A3-90B2-3FDE2DF18B70Q33709818-9DFA3CE0-7541-48F1-9CFC-33A034F4E838Q33709824-CD046027-DCEA-4F1F-95A8-B7099EE40276Q35028132-AB8780A5-840A-4BB6-BF8E-3EFB3FF55EBFQ35042577-DA6D09C9-3001-426D-92B4-D6FD5EBB9077Q35186542-0E2B302C-97E5-4686-9E32-ECF5B3856957Q37959029-E195EAF7-FE22-4F0B-92E1-3B8ABA8F1753Q41095531-F4EAC12D-59FE-4D48-9FC5-4A281B32045DQ41503845-E2BD6023-891F-4FBC-9385-6975ED248A55Q41612740-5202DE56-2499-46CC-A758-2578FE589734Q41881320-3E30E60F-434D-4F52-B35F-046FEC9579FCQ41952692-06F3A6B6-E98D-4475-A426-0BAB5B6DE97EQ42198666-BA311BA2-366D-4909-80C8-E238FF806E00Q42261970-B5ACFF24-8BA5-4147-BCA2-A7DAA271EF9AQ43134219-82FA183E-E30B-4127-BD25-B781C0A55716Q46274903-80D54750-8FC2-4034-B43D-2ED9FC441849
P2860
Regulation of potassium channels by nonsedating antihistamines.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Regulation of potassium channels by nonsedating antihistamines.
@en
Regulation of potassium channels by nonsedating antihistamines.
@nl
type
label
Regulation of potassium channels by nonsedating antihistamines.
@en
Regulation of potassium channels by nonsedating antihistamines.
@nl
prefLabel
Regulation of potassium channels by nonsedating antihistamines.
@en
Regulation of potassium channels by nonsedating antihistamines.
@nl
P356
P1433
P1476
Regulation of potassium channels by nonsedating antihistamines.
@en
P2093
P304
P356
10.1161/01.CIR.91.8.2220
P407
P577
1995-04-01T00:00:00Z